Patents by Inventor Henry Krutzsch

Henry Krutzsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5449753
    Abstract: The present invention relates, in general, to autotaxin. In particular, the present invention relates to a DNA segment encoding autotaxin; recombinant DNA molecules containing the DNA segment; cells containing the recombinant DNA molecule; a method of producing autotaxin; and antibodies to autotaxin.
    Type: Grant
    Filed: January 17, 1992
    Date of Patent: September 12, 1995
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mary Stracke, Lance A. Liotta, Elliott Schiffmann, Henry Krutzsch
  • Patent number: 5372809
    Abstract: A family of metalloproteinases exist which cleave extracellular matrix molecules. These metalloproteinases are secreted in a latent inactive form and require activation in order to specifically cleave the preferred substrate. A series of peptides have been prepared based on the complete sequence analysis of type IV procollagenase. Peptide inhibitors were synthesized which correspond to cysteine repeat regions and histidine containing regions; the mechanism of action of these peptides involves inhibition of binding of the enzyme to the substrate. Peptide inhibitors were synthesized which correspond to the peptide cleaved off during activation, and constitute a novel class of metalloproteinase inhibitors. These inhibitors are members of a series of peptides which contain the core amino acid sequence RKPRC or analogs thereof. The cysteine residue is required for activity.
    Type: Grant
    Filed: January 31, 1992
    Date of Patent: December 13, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Lance A. Liotta, William Stetler-Stevenson, Henry Krutzsch
  • Patent number: 5280106
    Abstract: A family of metalloproteinases exist which cleave extracellular matrix molecules. These metalloproteinases are secreted in a latent inactive form and require activation in order to specifically cleave the preferred substrate. A series of peptides have been prepared based on the complete sequence analysis of type IV procollagenase. Peptide inhibitors were synthesized which correspond to cysteine repeat regions and histidine containing regions; the mechanism of action of these peptides involves inhibition of binding of the enzyme to the substrate. Peptide inhibitors were synthesized which correspond to the peptide cleaved off during activation, and constitute a novel class of metalloproteinase inhibitors. These inhibitors are members of a series of peptides which contain the core amino acid sequence RKPRC or analogs thereof. The cysteine residue is required for activity.
    Type: Grant
    Filed: February 26, 1990
    Date of Patent: January 18, 1994
    Inventors: Lance A. Liotta, William Stetler-Stevenson, Henry Krutzsch
  • Patent number: 5270447
    Abstract: A family of metalloproteinases exist which cleave extracellular matrix molecules. These metalloproteinases are secreted in a latent inactive form and require activation in order to specifically cleave the preferred substrate. A series of peptides have been prepared based on the complete sequence analysis of type IV Procollagenase. Peptide inhibitors were synthesized which correspond to cysteine repeat regions and histidine containing regions; the mechanism of action of these peptides involves inhibition of binding of the enzyme to the substrate. Peptide inhibitors were synthesized which correspond to the peptide cleaved off during activation, and constitute a novel class of metalloproteinase inhibitors. These inhibitors are members of a series of peptides which contain the core amino acid sequence PRCG. The cysteine residue is required for activity.
    Type: Grant
    Filed: March 1, 1989
    Date of Patent: December 14, 1993
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Lance A. Liotta, William Stetler-Stevenson, Henry Krutzsch